The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples